Tamil Nadu Braces for Extended Heatwave With Temperatures Exceeding 40C Health Advisory Issued Standard Chartered to Slash Corporate Roles by Over 15 in Efficiency Drive Hindalco Q4 Net Profit Falls 51 on Novelis Fire Expenses Revenue Jumps 20 on Higher Metal Prices European Companies Maintain China Manufacturing Presence Amid EU Derisking Push IndustryEducation Collaboration Reshapes New Hampshires Advanced Manufacturing Landscape Mortgage Rates Extend Decline as Borrowing Costs Continue to Ease WSO Q1 2026 Earnings EPS Surpasses Estimates by 933 Stock Declines Marginally TGT Q1 2026 Earnings EPS Surprises to the Upside Stock Reacts Positively NanoViricides Inc NNVC Q1 2026 Earnings Narrower Loss Drives Positive Stock Reaction RYAAY Q1 2026 Earnings EPS Misses Widely Yet Shares Rally Koppers Holdings Q1 2026 Earnings EPS Surges Past Estimates Borr Drilling BORR Q1 2026 Earnings WiderthanExpected Loss as Offshore Market Challenges Persist Getty Images GETY Edges Higher Amid Volatility Key Support and Resistance Levels in Focus Trailblazer Acquisition Corp Unit BLZRU Holds Steady Near 1021 as Trading Activity Remains Subdued Greenland Mines Ltd GRML Holds Near Support at 037 After Modest Gain SKYX Platforms Corp SKYX Slides 225 as Shares Approach Critical Support Level Neuberger Municipal Fund Inc NBH Edges Higher Tests Key Resistance Zone HFCL Shares Surge 140 in Two Months on Strong Earnings and Export Orders PERI Q1 2026 Earnings EPS Misses Estimates as Stock Declines ONBPO Edges Higher Old National Bancorp Preferred Shares Approach Resistance Brookfield Renewable Partners Q1 2026 Earnings Widely Missed EPS Estimates as Operating Challenges Persist PPBT Q1 2025 Earnings Biotech Reports Net Loss Amid Ongoing Clinical Development MO Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick RMTI Q1 2026 Earnings EPS Miss Drags Stock Down 47 KOP Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Tiptree Inc TIPT Q2 2025 Earnings Strong Earnings Per Share Amid Quiet Quarter CRBP Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances